iifl-logo-icon 1

Bliss GVS Pharma Ltd Cash Flow Statement

124.61
(-5.40%)
Oct 22, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Bliss GVS Pharma FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2019

Profit before tax

123.65

91.18

121.71

120.01

Depreciation

-13.84

-13.76

-8.83

-5.74

Tax paid

-33.73

-23.68

-29.37

-45.57

Working capital

74.06

16.34

44.64

-0.64

Other operating items

Operating

150.13

70.07

128.15

68.03

Capital expenditure

58.6

8.59

108.89

9.89

Free cash flow

208.73

78.67

237.04

77.92

Equity raised

1,493.78

1,350.45

1,173.25

1,049.63

Investing

-0.03

0

0

0

Financing

46.01

41.95

32.44

3.02

Dividends paid

0

0

0

0

Net in cash

1,748.48

1,471.07

1,442.73

1,130.58

Bliss GVS Pharma : related Articles

No Record Found

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp